Iwahashi M - Search Results

1

Non-T cell disturbance causes the suppression of the autologous mixed lymphocyte reaction in patients with gastric carcinoma.

Iwahashi M, Tanimura H, Yamaue H, Tsunoda T, Tani M, Noguchi K, Mizobata S, Tamai M, Hotta T, Arii K. Iwahashi M, et al. Anticancer Res. 1995 May-Jun;15(3):799-804. Anticancer Res. 1995. PMID: 7645961

2

Enhancement of tumor cell susceptibility to lymphokine-activated killer cells by treatment with the streptococcal preparation OK432.

Yamaue H, Tanimura H, Tsunoda T, Iwahashi M, Tani M, Tamai M, Noguchi K, Hotta T, Arii K. Yamaue H, et al. Among authors: iwahashi m. Biotherapy. 1992;5(1):83-93. doi: 10.1007/BF02194788. Biotherapy. 1992. PMID: 1389905

3

Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay.

Yamaue H, Tanimura H, Noguchi K, Hotta T, Tani M, Tsunoda T, Iwahashi M, Tamai M, Iwakura S. Yamaue H, et al. Among authors: iwahashi m. Br J Cancer. 1992 Nov;66(5):794-9. doi: 10.1038/bjc.1992.362. Br J Cancer. 1992. PMID: 1419622 Free PMC article.

4

Defective autologous mixed lymphocyte reaction (AMLR) and killer activity generated in the AMLR in cancer patients.

Iwahashi M, Tanimura H, Yamaue H, Tsunoda T, Tani M, Tamai M, Noguchi K, Hotta T. Iwahashi M, et al. Int J Cancer. 1992 Apr 22;51(1):67-71. doi: 10.1002/ijc.2910510114. Int J Cancer. 1992. PMID: 1532952

5

The promotive effect of interleukin 4 with interleukin 2 in the proliferation of tumor-infiltrating lymphocytes from patients with malignant tumor.

Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Arii K, Noguchi K. Tsunoda T, et al. Among authors: iwahashi m. Biotherapy. 1992;4(1):9-15. doi: 10.1007/BF02171704. Biotherapy. 1992. PMID: 1543654

6

Clinical and immunological evaluation of intraoperative radiation therapy for patients with unresectable pancreatic cancer.

Yamaue H, Tanimura H, Aoki Y, Tsunoda T, Iwahashi M, Tani M, Tamai M, Noguchi K, Kashiwagi H, Sasaki M, et al. Yamaue H, et al. Among authors: iwahashi m. J Surg Oncol. 1992 Jan;49(1):10-5. doi: 10.1002/jso.2930490104. J Surg Oncol. 1992. PMID: 1548874

7

In vitro augmentation of the cytotoxic activity of peripheral blood mononuclear cells and tumor-infiltrating lymphocytes by famotidine in cancer patients.

Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Arii K, Noguchi K. Tsunoda T, et al. Among authors: iwahashi m. Int J Immunopharmacol. 1992 Jan;14(1):75-81. doi: 10.1016/0192-0561(92)90107-v. Int J Immunopharmacol. 1992. PMID: 1582736

8

In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan.

Tani M, Tanimura H, Yamaue H, Iwahashi M, Tsunoda T, Tamai M, Noguchi K, Arii K. Tani M, et al. Among authors: iwahashi m. Eur J Clin Pharmacol. 1992;42(6):623-7. doi: 10.1007/BF00265926. Eur J Clin Pharmacol. 1992. PMID: 1623902

9

Cisplatin treatment renders tumor cells more susceptible to attack by lymphokine-activated killer cells.

Yamaue H, Tanimura H, Noguchi K, Iwahashi M, Tsunoda T, Tani M, Tamai M, Hotta T, Mizobata S, Arii K. Yamaue H, et al. Among authors: iwahashi m. J Clin Lab Immunol. 1991 Aug;35(4):165-70. J Clin Lab Immunol. 1991. PMID: 1668852

10

Functional and phenotypic analyses of interleukin 2-activated tumor-infiltrating lymphocytes.

Yamaue H, Tanimura H, Tsunoda T, Iwahashi M, Tani M, Tamai M, Inoue M. Yamaue H, et al. Among authors: iwahashi m. Biotherapy. 1990;2(3):247-59. doi: 10.1007/BF02173526. Biotherapy. 1990. PMID: 1698423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters